TC BioPharm Information
Contact top employees from
TC BioPharm
Summary
TC BioPharm is a private company that has been in the industry for 12 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Chairman & CEO is occupied by Michael Leek. Its headquarters is located at Holytown, Scotland, GB. The number of employees ranges from 25 to 100. The annual revenue of TC BioPharm varies between 100K and 5.0M. Total funding of the company - $14M. To connect with TC BioPharm employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
Specialties
Clinical Grade Cell Therapy, Cancer Immonotherapy, Regenerative Medicine, Stratified Medicine
SIC Code
2834
Founded
2014
Estimated Annual Revenue
$100K - 5.0M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2009 | Public Company | 1.0K - 5.0K | 45M | $634.9M | |
| 2008 | Privately Held | 25 - 100 | 2.2M | $160.5M | |
| 1993 | Public Company | 1.0K - 5.0K | 50.2M | $526.4M | |
| 2000 | Public Company | 100 - 250 | 38.4M | $361.3M | |
| 2008 | Privately Held | 250 - 500 | 40.9M | $923.3M | |
| 2016 | Privately Held | 25 - 100 | 2M | $121.9M | |
| 2015 | Public Company | 100 - 250 | < 1M | $269.5M | |
| 2013 | Public Company | 100 - 250 | 89.2M | $204.8M | |
| 2008 | Public Company | 250 - 500 | 3.6M | $358.7M | |
| 2013 | Public Company | 1.0K - 5.0K | 106M | $1.5B | |
| 1979 | Public Company | 250 - 500 | 6.5M | $296.4M | |
| 1848 | Public Company | 50K - 100K | 55.5B | $0 | |
| 1996 | Public Company | 100K - 9.9M | 50.4B | $0 | |
| 1891 | Public Company | 50K - 100K | 50.1B | $0 | |
| 1994 | Public Company | 200-500 | - | $- | |
| 2008 | - | 1000-5000 | - | $- | |
| 1980 | - | 10000+ | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at TC BioPharm shows a diverse range of experience levels:
4% have been with the company for less than 1 year11% for 1–2 years21% for 3–4 years25% for 5–7 years29% for 8–10 years11% have over 11 years of service at TC BioPharmEx-employees positions
In Company
In New Company
Contact top employees from
TC BioPharm
Mark Bonyhadi
Advisor and Consultant
Chris Camarra
Executive Vice President Communications
Gilbert Feldma
CEO
